Serial Number | 86578521 |
Word Mark | AMGEN BIOSIMILARS |
Filing Date | Friday, March 27, 2015 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, April 1, 2019 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, January 5, 2016 |
Disclaimer with Predetermined Text | "BIOSIMILARS" |
Description of Mark | The mark consists of the stylized words "AMGEN BIOSIMILARS" positioned to the right of an interweaving double ribbon design. |
Goods and Services | House mark for a full line of pharmaceuticals and pharmaceutical preparations, namely, pharmaceutical preparations and substances used for the treatment of bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune, immune system, inflammatory, inflammatory bowel, gastrointestinal, genitourinary, musculoskeletal, dermatological, pulmonary, respiratory, oncological, hepatological, lymphomas, leukemias, ophthalmic, transplant rejection, cardiovascular, endocrine, neurological, sleep, muscular, and psychiatric diseases and disorders;pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, polymyalgia rheumatic, spondyloarthropathies, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, autoimmune pancreatitis, multiple myeloma, multiple sclerosis, systemic lupus erythematosus, lupus nephritis, chronic inflammatory demyelinating polyneuropathy, autoimmune anemia, autoimmune hemolytic anemia, pure red cell aplasia, idiopathic thrombocytopenic purpura, Evans syndrome, type 1 diabetes mellitus, Sjogren's syndrome, encephalitis, IgG4-related disease, Devic's disease, myositis, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, palmoplantar psoriasis, hidradenitis suppurativa, bullous skin disorder, pemphigus, pemphigoid, kawasaki disease, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, age-related macular degeneration, refractory diabetic macular edema, uveitis, childhood uveitis, uveitic macular edema, choroidal neovascularization, Graves' ophthalmopathy, pyoderma gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancer, breast cancer, ovarian cancer, cervical cancer, gastric cancer, colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, head and neck cancer, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, lymphocyte predominant subtype of Hodgkin's Lymphoma, vasculitis, granulomatosis with polyangiitis, microscopic polyangiitis, graft-versus-host disease, graft-versus-host disease following allogenic hematopoietic stem cell transplantation, graft-versus-host disease following keratoprosthesis, kidney transplant, asthma, chronic fatigue syndrome, major depression, and bipolar depression |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 6, 2015 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Amgen Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Thousand Oaks, CA 913201799 |
Party Name | Amgen Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Thousand Oaks, CA 913201799 |
Event Date | Event Description |
Monday, April 1, 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, April 1, 2019 | ABANDONMENT - NO USE STATEMENT FILED |
Thursday, March 7, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, March 7, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, August 22, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, August 21, 2018 | EXTENSION 5 GRANTED |
Wednesday, August 15, 2018 | EXTENSION 5 FILED |
Tuesday, August 21, 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Wednesday, August 15, 2018 | TEAS EXTENSION RECEIVED |
Friday, March 2, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, February 28, 2018 | EXTENSION 4 GRANTED |
Wednesday, February 28, 2018 | EXTENSION 4 FILED |
Wednesday, February 28, 2018 | TEAS EXTENSION RECEIVED |
Thursday, August 10, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, August 8, 2017 | EXTENSION 3 GRANTED |
Tuesday, August 8, 2017 | EXTENSION 3 FILED |
Tuesday, August 8, 2017 | TEAS EXTENSION RECEIVED |
Wednesday, March 1, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, February 27, 2017 | EXTENSION 2 GRANTED |
Monday, February 27, 2017 | EXTENSION 2 FILED |
Monday, February 27, 2017 | TEAS EXTENSION RECEIVED |
Thursday, July 7, 2016 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, July 5, 2016 | EXTENSION 1 GRANTED |
Tuesday, July 5, 2016 | EXTENSION 1 FILED |
Tuesday, July 5, 2016 | TEAS EXTENSION RECEIVED |
Tuesday, March 1, 2016 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, January 5, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, January 5, 2016 | PUBLISHED FOR OPPOSITION |
Wednesday, December 16, 2015 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Thursday, November 12, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, November 12, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, November 11, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, November 11, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, May 18, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, May 18, 2015 | NON-FINAL ACTION E-MAILED |
Monday, May 18, 2015 | NON-FINAL ACTION WRITTEN |
Monday, May 11, 2015 | ASSIGNED TO EXAMINER |
Tuesday, April 7, 2015 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Monday, April 6, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Tuesday, March 31, 2015 | NEW APPLICATION ENTERED IN TRAM |